Understanding cardiovascular disease: A journey through the genome (and what we found there)

DMM Disease Models and Mechanisms

Volumn 5, Issue 4, 2012, Pages 434-443

  Lara Pezzi, Enrique ^a   Dopazo, Ana ^a   Manzanares, Miguel ^a  

^a CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA;

ALTERNATIVE RNA SPLICING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHROMATIN; EXOME; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOME; HOSPITALIZATION; HUMAN; INHERITANCE; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

CARDIOVASCULAR DISEASES; EXOME; GENOME, HUMAN; GENOME-WIDE ASSOCIATION STUDY; HUMANS; INHERITANCE PATTERNS; QUANTITATIVE TRAIT LOCI;

EID: 84863477017     PISSN: 17548403     EISSN: 17548411     Source Type: Journal    
DOI: 10.1242/dmm.009787     Document Type: Review

References (109)

1. Baek, D., Villén, J., Shin, C., Camargo, F. D., Gygi, S. P. and Bartel, D. P. (2008). The impact of microRNAs on protein output. Nature 455, 64-71.
2. Bamshad, M. J., Ng, S. B., Bigham, A. W., Tabor, H. K., Emond, M. J., Nickerson, D. A. and Shendure, J. (2011). Exome sequencing as a tool for Mendelian disease gene discovery. Nat. Rev. Genet. 12, 745-755.
3. Bartel, D. P. and Chen, C. Z. (2004). Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs. Nat. Rev. Genet. 5, 396-400. (Pubitemid 38529411)
4. Bastiaenen, R. and Behr, E. R. (2011). Sudden death and ion channel disease: pathophysiology and implications for management. Heart 97, 1365-1372.
5. Bellenguez, C., Bevan, S., Gschwendtner, A., Spencer, C. C., Burgess, A. I., Pirinen, M., Jackson, C. A., Traylor, M., Strange, A., Su, Z. et al. (2012). Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke. Nat. Genet. 44, 328-333.
6. Birney, E., Stamatoyannopoulos, J. A., Dutta, A., Guigo, R., Gingeras, T. R., Margulies, E. H., Weng, Z., Snyder, M., Dermitzakis, E. T., Thurman, R. E. et al. (2007). Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 447, 799-816.
7. Blow, M. J., McCulley, D. J., Li, Z., Zhang, T., Akiyama, J. A., Holt, A., Plajzer-Frick, I., Shoukry, M., Wright, C., Chen, F. et al. (2010). ChIP-Seq identification of weakly conserved heart enhancers. Nat. Genet. 42, 806-810.
8. Burton, P. R., Clayton, C. D., Cardon, L. R., Craddock, N., Deloukas, P., Duncanson, A., Kwiatkowski, D. P., McCarthy, M. I., Ouwehand, W. H., Samani, N. J. et al. (2007). Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447, 661-678. (Pubitemid 46889737)
9. Cantor, R. M., Lange, K. and Sinsheimer, J. S. (2010). Prioritizing GWAS results: A review of statistical methods and recommendations for their application. Am. J. Hum. Genet. 86, 6-22.
10. Carvajal-Vergara, X., Sevilla, A., D'Souza, S. L., Ang, Y. S., Schaniel, C., Lee, D. F., Yang, L., Kaplan, A. D., Adler, E. D., Rozov, R. et al. (2010). Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome. Nature 465, 808-812.
11. Cesana, M., Cacchiarelli, D., Legnini, I., Santini, T., Sthandier, O., Chinappi, M., Tramontano, A. and Bozzoni, I. (2011). A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA. Cell 147, 358-369.
12. Chambers, I. and Tomlinson, S. R. (2009). The transcriptional foundation of pluripotency. Development 136, 2311-2322.
13. Chang, C.-P. and Bruneau, B. (2012). Epigenetics and cardiovascular development. Annu. Rev. Physiol. 74, 41-68.
14. Chang, S., McKinsey, T. A., Zhang, C. L., Richardson, J. A., Hill, J. A. and Olson, E. N. (2004). Histone deacetylases 5 and 9 govern responsiveness of the heart to a subset of stress signals and play redundant roles in heart development. Mol. Cell. Biol. 24, 8467-8476. (Pubitemid 39245069)
15. Conrad, D. F., Keebler, J. E., DePristo, M. A., Lindsay, S. J., Zhang, Y., Casals, F., Idaghdour, Y., Hartl, C. L., Torroja, C., Garimella, K. V. et al. (2011). Variation in genome-wide mutation rates within and between human families. Nat. Genet. 43, 712-714.
16. Cooper, G. M. and Shendure, J. (2011). Needles in stacks of needles: finding disease-causal variants in a wealth of genomic data. Nat. Rev. Genet. 12, 628-640.
17. de Almeida, S. F., Grosso, A. R., Koch, F., Fenouil, R., Carvalho, S., Andrade, J., Levezinho, H., Gut, M., Eick, D., Gut, I. et al. (2011). Splicing enhances recruitment of methyltransferase HYPB/Setd2 and methylation of histone H3 Lys36. Nat. Struct. Mol. Biol. 18, 977-983.
18. De Santa, F., Barozzi, I., Mietton, F., Ghisletti, S., Polletti, S., Tusi, B. K., Muller, H., Ragoussis, J., Wei, C.-L. and Natoli, G. (2010). A large fraction of extragenic RNA Pol II transcription sites overlap enhancers. PLoS Biol. 8, e1000384.
19. de Wit, E. and de Laat, W. (2012). A decade of 3C technologies: insights into nuclear organization. Genes Dev. 26, 11-24.
20. Dermitzakis, E. T., Reymond, A., Lyle, R., Scamuffa, N., Ucla, C., Deutsch, S., Stevenson, B. J., Flegel, V., Bucher, P., Jongeneel, C. V. et al. (2002). Numerous potentially functional but non-genic conserved sequences on human chromosome 21. Nature 420, 578-582. (Pubitemid 35477051)
21. Ding, J. H., Xu, X., Yang, D., Chu, P. H., Dalton, N. D., Ye, Z., Yeakley, J. M., Cheng, H., Xiao, R. P., Ross, J. et al. (2004). Dilated cardiomyopathy caused by tissuespecific ablation of SC35 in the heart. EMBO J. 23, 885-896. (Pubitemid 38418755)
22. Dube, J. B., Johansen, C. T. and Hegele, R. A. (2011). Sortilin: an unusual suspect in cholesterol metabolism: from GWAS identification to in vivo biochemical analyses, sortilin has been identified as a novel mediator of human lipoprotein metabolism. BioEssays 33, 430-437.
23. Felkin, L. E., Narita, T., Germack, R., Shintani, Y., Takahashi, K., Sarathchandra, P., López-Olañeta, M. M., Gómez-Salinero, J. M., Suzuki, K., Barton, P. J. R. et al. (2011). Calcineurin splicing variant CnAb1 improves cardiac function after myocardial infarction without inducing hypertrophy. Circulation 123, 2838-2847.
24. Feng, H.-Z. and Jin, J. P. (2010). Coexistence of cardiac troponin T variants reduces heart efficiency. Am. J. Physiol. Heart Circ. Physiol. 299, H97-H105.
25. Franco-Zorrilla, J. M., Valli, A., Todesco, M., Mateos, I., Puga, M. I., Rubio-Somoza, I., Leyva, A., Weigel, D., Garcia, J. A. and Paz-Ares, J. (2007). Target mimicry provides a new mechanism for regulation of microRNA activity. Nat. Genet. 39, 1033-1037. (Pubitemid 47185180)
26. Guo, W., Schafer, S., Greaser, M. L., Radke, M. H., Liss, M., Govindarajan, T., Maatz, H., Schulz, H., Li, S., Parrish, A. M. et al. (2012). RBM20, a gene for hereditary cardiomyopathy, regulates titin splicing. Nat. Med. [Epub ahead of print] Doi: 10.1038/nm2693.
27. Haberland, M., Montgomery, R. L. and Olson, E. N. (2009). The many roles of histone deacetylases in development and physiology: implications for disease and therapy. Nat. Rev. Genet. 10, 32-42.
28. Hang, C. T., Yang, J., Han, P., Cheng, H.-L., Shang, C., Ashley, E., Zhou, B. and Chang, C.-P. (2010). Chromatin regulation by Brg1 underlies heart muscle development and disease. Nature 466, 62-67.
29. Harismendy, O., Notani, D., Song, X., Rahim, N. G., Tanasa, B., Heintzman, N., Ren, B., Fu, X. D., Topol, E. J., Rosenfeld, M. G. et al. (2011). 9p21 DNA variants associated with coronary artery disease impair interferon-gamma signalling response. Nature 470, 264-268.
30. He, A., Kong, S. W., Ma, Q. and Pu, W. T. (2011). Co-occupancy by multiple cardiac transcription factors identifies transcriptional enhancers active in heart. Proc. Natl. Acad. Sci. USA 108, 5632-5637.
31. Heinig, M., Petretto, E., Wallace, C., Bottolo, L., Rotival, M., Lu, H., Li, Y., Sarwar, R., Langley, S. R., Bauerfeind, A. et al. (2010). A trans-acting locus regulates an antiviral expression network and type 1 diabetes risk. Nature 467, 460-464.
32. Heintzman, N. D., Stuart, R. K., Hon, G., Fu, Y., Ching, C. W., Hawkins, R. D., Barrera, L. O., Van Calcar, S., Qu, C., Ching, K. A. et al. (2007). Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat. Genet. 39, 311-318. (Pubitemid 46328487)
33. Helgadottir, A., Thorleifsson, G., Manolescu, A., Gretarsdottir, S., Blondal, T., Jonasdottir, A., Sigurdsson, A., Baker, A., Palsson, A., Masson, G. et al. (2007). A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science 316, 1491-1493. (Pubitemid 46906618)
34. Hirschhorn, J. N. and Daly, M. J. (2005). Genome-wide association studies for common diseases and complex traits. Nat. Rev. Genet. 6, 95-108. (Pubitemid 40179532)
35. Hoffman, J. I. and Kaplan, S. (2002). The incidence of congenital heart disease. J. Am. Coll. Cardiol. 39, 1890-1900. (Pubitemid 34628268)
36. Ioannidis, J. P., Ntzani, E. E., Trikalinos, T. A. and Contopoulos-Ioannidis, D. G. (2001). Replication validity of genetic association studies. Nat. Genet. 29, 306-309. (Pubitemid 33096456)
37. Itzhaki, I., Maizels, L., Huber, I., Zwi-Dantsis, L., Caspi, O., Winterstern, A., Feldman, O., Gepstein, A., Arbel, G., Hammerman, H. et al. (2011). Modelling the long QT syndrome with induced pluripotent stem cells. Nature 471, 225-229.
38. Johansen, C. T., Wang, J., Lanktree, M. B., Cao, H., McIntyre, A. D., Ban, M. R., Martins, R. A., Kennedy, B. A., Hassell, R. G., Visser, M. E. et al. (2010). Excess of rare variants in genes identified by genome-wide association study of hypertriglyceridemia. Nat. Genet. 42, 684-687.
39. Kalsotra, A., Wang, K., Li, P.-F. and Cooper, T. A. (2010). MicroRNAs coordinate an alternative splicing network during mouse postnatal heart development. Genes Dev. 24, 653-658.
40. Kim, S., Kim, H., Fong, N., Erickson, B. and Bentley, D. L. (2011). Pre-mRNA splicing is a determinant of histone H3K36 methylation. Proc. Natl. Acad. Sci. USA 108, 13564-13569.
41. Kim, T.-K., Hemberg, M., Gray, J. M., Costa, A. M., Bear, D. M., Wu, J., Harmin, D. A., Laptewicz, M., Barbara-Haley, K., Kuersten, S. et al. (2010). Widespread transcription at neuronal activity-regulated enhancers. Nature 465, 182-187.
42. Kong, S. W., Hu, Y. W., Ho, J. W. K., Ikeda, S., Polster, S., John, R., Hall, J. L., Bisping, E., Pieske, B., dos Remedios, C. G. et al. (2010). Heart failure-associated changes in RNA splicing of sarcomere genes. Circ. Cardiovasc. Genet. 3, 138-146.
43. Ladd, A. N., Taffet, G., Hartley, C., Kearney, D. L. and Cooper, T. A. (2005). Cardiac tissue-specific repression of CELF activity disrupts alternative splicing and causes cardiomyopathy. Mol. Cell. Biol. 25, 6267-6278. (Pubitemid 40946574)
44. Latronico, M. V. G. and Condorelli, G. (2009). MicroRNAs and cardiac pathology. Nat. Rev. Cardiol. 6, 418-429.
45. Lee, J.-H., Gao, C., Peng, G., Greer, C., Ren, S., Wang, Y. and Xiao, X. (2011). Analysis of transcriptome complexity through RNA sequencing in normal and failing murine hearts / novelty and significance. Circ. Res. 109, 1332-1341.
46. Lee, S., Lee, J. W. and Lee, S.-K. (2012). UTX, a histone H3-lysine 27 demethylase, acts as a critical switch to activate the cardiac developmental program. Dev. Cell 22, 25-37.
47. Lee, Y., Song, A. J., Baker, R., Micales, B., Conway, S. J. and Lyons, G. E. (2000). Jumonji, a nuclear protein that is necessary for normal heart development. Circ. Res. 86, 932-938. (Pubitemid 30324304)
48. Lickert, H., Takeuchi, J. K., von Both, I., Walls, J. R., McAuliffe, F., Lee Adamson, S., Mark Henkelman, R., Wrana, J. L., Rossant, J. and Bruneau, B. G. (2004). Baf60c is essential for function of BAF chromatin remodelling complexes in heart development. Nature 432, 107-112. (Pubitemid 39490836)
49. Luco, R. F., Pan, Q., Tominaga, K., Blencowe, B. J., Pereira-Smith, O. M. and Misteli, T. (2010). Regulation of alternative splicing by histone modifications. Science 327, 996-1000.
50. Lupski, J. R., Belmont, J. W., Boerwinkle, E. and Gibbs, R. A. (2011). Clan genomics and the complex architecture of human disease. Cell 147, 32-43.
51. MacArthur, D. G. and Tyler-Smith, C. (2010). Loss-of-function variants in the genomes of healthy humans. Hum. Mol. Genet. 19, R125-R130.
52. Makarenko, I., Opitz, C. A., Leake, M. C., Neagoe, C., Kulke, M., Gwathmey, J. K., del Monte, F., Hajjar, R. J. and Linke, W. A. (2004). Passive stiffness changes caused by upregulation of compliant titin isoforms in human dilated cardiomyopathy hearts. Circ. Res. 95, 708-716. (Pubitemid 39331931)
53. Manolio, T. A., Collins, F. S., Cox, N. J., Goldstein, D. B., Hindorff, L. A., Hunter, D. J., McCarthy, M. I., Ramos, E. M., Cardon, L. R., Chakravarti, A. et al. (2009). Finding the missing heritability of complex diseases. Nature 461, 747-753.
54. May, D., Blow, M. J., Kaplan, T., McCulley, D. J., Jensen, B. C., Akiyama, J. A., Holt, A., Plajzer-Frick, I., Shoukry, M., Wright, C. et al. (2011). Large-scale discovery of enhancers from human heart tissue. Nat. Genet. 44, 89-93.
55. McDermott-Roe, C., Ye, J., Ahmed, R., Sun, X.-M., Serafin, A., Ware, J., Bottolo, L., Muckett, P., Canas, X., Zhang, J. et al. (2011). Endonuclease G is a novel determinant of cardiac hypertrophy and mitochondrial function. Nature 478, 114-118.
56. McPherson, R., Pertsemlidis, A., Kavaslar, N., Stewart, A., Roberts, R., Cox, D. R., Hinds, D. A., Pennacchio, L. A., Tybjaerg-Hansen, A., Folsom, A. R. et al. (2007). A common allele on chromosome 9 associated with coronary heart disease. Science 316, 1488-1491. (Pubitemid 46906617)
57. Miyamoto, S., Kawamura, T., Morimoto, T., Ono, K., Wada, H., Kawase, Y., Matsumori, A., Nishio, R., Kita, T. and Hasegawa, K. (2006). Histone acetyltransferase activity of p300 is required for the promotion of left ventricular remodeling after myocardial infarction in adult mice in vivo. Circulation 113, 679-690.
58. Morgan, T. M., Krumholz, H. M., Lifton, R. P. and Spertus, J. A. (2007). Nonvalidation of reported genetic risk factors for acute coronary syndrome in a large-scale replication study. JAMA 297, 1551-1561. (Pubitemid 46588368)
59. Movassagh, M., Choy, M.-K., Knowles, D. A., Cordeddu, L., Haider, S., Down, T., Siggens, L., Vujic, A., Simeoni, I., Penkett, C. et al. (2011). Distinct epigenomic features in end-stage failing human hearts. Circulation 124, 2411-2422.
60. Mudd, J. O. and Kass, D. A. (2008). Tackling heart failure in the twenty-first century. Nature 451, 919-928. (Pubitemid 351301747)
61. Musunuru, K., Pirruccello, J. P., Do, R., Peloso, G. M., Guiducci, C., Sougnez, C., Garimella, K. V., Fisher, S., Abreu, J., Barry, A. J. et al. (2010). Exome sequencing, ANGPTL3 mutations, and familial combined hypolipidemia. N. Engl. J. Med. 363, 2220-2227.
62. Myers, R. H., Kiely, D. K., Cupples, L. A. and Kannel, W. B. (1990). Parental history is an independent risk factor for coronary artery disease: the Framingham Study. Am. Heart J. 120, 963-969. (Pubitemid 20346165)
63. Myers, R. M., Stamatoyannopoulos, J., Snyder, M., Dunham, I., Hardison, R. C., Bernstein, B. E., Gingeras, T. R., Kent, W. J., Birney, E., Wold, B. et al. (2011). A user's guide to the encyclopedia of DNA elements (ENCODE). PLoS Biol. 9, e1001046.
64. Narlikar, L., Sakabe, N. J., Blanski, A. A., Arimura, F. E., Westlund, J. M., Nobrega, M. A. and Ovcharenko, I. (2010). Genome-wide discovery of human heart enhancers. Genome Res. 20, 381-392.
65. Newton-Cheh, C., Eijgelsheim, M., Rice, K. M., de Bakker, P. I., Yin, X., Estrada, K., Bis, J. C., Marciante, K., Rivadeneira, F., Noseworthy, P. A. et al. (2009). Common variants at ten loci influence QT interval duration in the QTGEN Study. Nat. Genet. 41, 399-406.
66. Nguyen, A. T., Xiao, B., Neppl, R. L., Kallin, E. M., Li, J., Chen, T., Wang, D.-Z., Xiao, X. and Zhang, Y. (2011). DOT1L regulates dystrophin expression and is critical for cardiac function. Genes Dev. 25, 263-274.
67. North, K. E., Howard, B. V., Welty, T. K., Best, L. G., Lee, E. T., Yeh, J. L., Fabsitz, R. R., Roman, M. J. and MacCluer, J. W. (2003). Genetic and environmental contributions to cardiovascular disease risk in American Indians: the strong heart family study. Am. J. Epidemiol. 157, 303-314. (Pubitemid 36193933)
68. Norton, N., Li, D., Rieder, M. J., Siegfried, J. D., Rampersaud, E., Zuchner, S., Mangos, S., Gonzalez-Quintana, J., Wang, L., McGee, S. et al. (2011). Genomewide studies of copy number variation and exome sequencing identify rare variants in BAG3 as a cause of dilated cardiomyopathy. Am. J. Hum. Genet. 88, 273-282.
69. O'Donnell, C. J. and Nabel, E. G. (2011). Genomics of cardiovascular disease. N. Engl. J. Med. 365, 2098-2109.
70. Ohtani, K. and Dimmeler, S. (2011). Epigenetic regulation of cardiovascular differentiation. Cardiovasc. Res. 90, 404-412.
71. Ong, C.-T. and Corces, V. G. (2011). Enhancer function: new insights into the regulation of tissue-specific gene expression. Nat. Rev. Genet. 12, 283-293.
72. Ordovas, J. M. and Smith, C. E. (2010). Epigenetics and cardiovascular disease. Nat. Rev. Cardiol. 7, 510-519.
73. Ørom, U. A., Derrien, T., Beringer, M., Gumireddy, K., Gardini, A., Bussotti, G., Lai, F., Zytnicki, M., Notredame, C., Huang, Q. et al. (2010). Long noncoding RNAs with enhancer-like function in human cells. Cell 143, 46-58.
74. Pandey, J. P. (2010). Genomewide association studies and assessment of risk of disease. N. Engl. J. Med. 363, 2076-2077.
75. Pasmant, E., Sabbagh, A., Vidaud, M. and Bieche, I. (2011). ANRIL, a long, noncoding RNA, is an unexpected major hotspot in GWAS. FASEB J. 25, 444-448.
76. Petretto, E., Mangion, J., Dickens, N. J., Cook, S. A., Kumaran, M. K., Lu, H., Fischer, J., Maatz, H., Kren, V., Pravenec, M. et al. (2006). Heritability and tissue specificity of expression quantitative trait loci. PLoS Genet. 2, e172.
77. Petretto, E., Sarwar, R., Grieve, I., Lu, H., Kumaran, M. K., Muckett, P. J., Mangion, J., Schroen, B., Benson, M., Punjabi, P. P. et al. (2008). Integrated genomic approaches implicate osteoglycin (Ogn) in the regulation of left ventricular mass. Nat. Genet. 40, 546-552. (Pubitemid 351601220)
78. Powell, J. E., Henders, A. K., McRae, A. F., Wright, M. J., Martin, N. G., Dermitzakis, E. T., Montgomery, G. W. and Visscher, P. M. (2011). Genetic control of gene expression in whole blood and lymphoblastoid cell lines is largely independent. Genome Res. 22, 456-466.
79. Qiu, H., Dai, H., Jain, K., Shah, R., Hong, C., Pain, J., Tian, B., Vatner, D. E., Vatner, S. F. and Depre, C. (2008). Characterization of a novel cardiac isoform of the cell cycle-related kinase that is regulated during heart failure. J. Biol. Chem. 283, 22157-22165.
80. Rada-Iglesias, A., Bajpai, R., Swigut, T., Brugmann, S. A., Flynn, R. A. and Wysocka, J. (2011). A unique chromatin signature uncovers early developmental enhancers in humans. Nature 470, 279-283.
81. Rana, T. M. (2007). Illuminating the silence: understanding the structure and function of small RNAs. Nat. Rev. Mol. Cell. Biol. 8, 23-36.
82. Ruan, Y., Liu, N. and Priori, S. G. (2009). Sodium channel mutations and arrhythmias. Nat. Rev. Cardiol. 6, 337-348.
83. Samani, N. J., Erdmann, J., Hall, A. S., Hengstenberg, C., Mangino, M., Mayer, B., Dixon, R. J., Meitinger, T., Braund, P., Wichmann, H. E. et al. (2007). Genomewide association analysis of coronary artery disease. N. Engl. J. Med. 357, 443-453. (Pubitemid 47204873)
84. Schlesinger, J., Schueler, M., Grunert, M., Fischer, J. J., Zhang, Q., Krueger, T., Lange, M., Tonjes, M., Dunkel, I. and Sperling, S. R. (2011). The cardiac transcription network modulated by Gata4, Mef2a, Nkx2.5, Srf, histone modifications, and microRNAs. PLoS Genet. 7, e1001313.
85. Shang, L. L., Pfahnl, A. E., Sanyal, S., Jiao, Z., Allen, J., Banach, K., Fahrenbach, J., Weiss, D., Taylor, W. R., Zafari, A. M. et al. (2007). Human heart failure is associated with abnormal C-terminal splicing variants in the cardiac sodium channel. Circ. Res. 101, 1146-1154. (Pubitemid 350146441)
86. Shea, S., Ottman, R., Gabrieli, C., Stein, Z. and Nichols, A. (1984). Family history as an independent risk factor for coronary artery disease. J. Am. Coll. Cardiol. 4, 793-801. (Pubitemid 14012469)
87. Song, L., Zhang, Z., Grasfeder, L. L., Boyle, A. P., Giresi, P. G., Lee, B. K., Sheffield, N. C., Graf, S., Huss, M., Keefe, D. et al. (2011). Open chromatin defined by DNaseI and FAIRE identifies regulatory elements that shape cell-type identity. Genome Res. 21, 1757-1767.
88. Splawski, I., Shen, J., Timothy, K. W., Lehmann, M. H., Priori, S., Robinson, J. L., Moss, A. J., Schwartz, P. J., Towbin, J. A., Vincent, G. M. et al. (2000). Spectrum of mutations in long-QT syndrome genes. KVLQT1, HERG, SCN5A, KCNE1, and KCNE2. Circulation 102, 1178-1185.
89. Srivastava, D. (2006). Making or breaking the heart: from lineage determination to morphogenesis. Cell 126, 1037-1048.
90. Stein, A. B., Jones, T. A., Herron, T. J., Patel, S. R., Day, S. M., Noujaim, S. F., Milstein, M. L., Klos, M., Furspan, P. B., Jalife, J. et al. (2011). Loss of H3K4 methylation destabilizes gene expression patterns and physiological functions in adult murine cardiomyocytes. J. Clin. Invest. 121, 2641-2650.
91. Szulwach, K. E., Li, X., Smrt, R. D., Li, Y., Luo, Y., Lin, L., Santistevan, N. J., Li, W., Zhao, X. and Jin, P. (2010). Cross talk between microRNA and epigenetic regulation in adult neurogenesis. J. Cell Biol. 189, 127-141.
92. Tariq, M., Belmont, J. W., Lalani, S., Smolarek, T. and Ware, S. M. (2011). SHROOM3 is a novel candidate for heterotaxy identified by whole exome sequencing. Genome Biol. 12, R91.
93. Tay, Y., Kats, L., Salmena, L., Weiss, D., Tan Shen, M., Ala, U., Karreth, F., Poliseno, L., Provero, P., Di Cunto, F. et al. (2011). Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs. Cell 147, 344-357.
94. Tester, D. J. and Ackerman, M. J. (2011). Genetic testing for potentially lethal, highly treatable inherited cardiomyopathies/channelopathies in clinical practice. Circulation 123, 1021-1037.
95. Thanassoulis, G. and Vasan, R. S. (2010). Genetic cardiovascular risk prediction: will we get there? Circulation 122, 2323-2334.
96. Thanassoulis, G., Peloso, G. M., Pencina, M. J., Hoffmann, U., Fox, C. S., Cupples, L. A., Levy, D., D'Agostino, R. B., Sr, Hwang, S. J. and O'Donnell, C. J. (2012). A genetic risk score is associated with incident cardiovascular disease and coronary artery calcium: the Framingham Heart Study. Circ. Cardiovasc. Genet. 5, 113-121.
97. Toyoda, M., Shirato, H., Nakajima, K., Kojima, M., Takahashi, M., Kubota, M., Suzuki-Migishima, R., Motegi, Y., Yokoyama, M. and Takeuchi, T. (2003). Jumonji downregulates cardiac cell proliferation by repressing cyclin D1 expression. Dev. Cell 5, 85-97. (Pubitemid 36827344)
98. Trivedi, C. M., Luo, Y., Yin, Z., Zhang, M., Zhu, W., Wang, T., Floss, T., Goettlicher, M., Noppinger, P. R., Wurst, W. et al. (2007). Hdac2 regulates the cardiac hypertrophic response by modulating Gsk3[beta] activity. Nat. Med. 13, 324-331. (Pubitemid 46376684)
99. Wang, G. S., Kearney, D. L., Biasi, M. D., Taffet, G. and Cooper, T. A. (2007). Elevation of RNA-binding protein CUGBP1 is an early event in an inducible heart-specific mouse model of myotonic dystrophy. J. Clin. Invest. 117, 2802-2811. (Pubitemid 47529611)
100. Wang, Z. and Burge, C. B. (2008). Splicing regulation: from a parts list of regulatory elements to an integrated splicing code. RNA 14, 802-813. (Pubitemid 351574901)
101. Watkins, H., Ashrafian, H. and Redwood, C. (2011). Inherited cardiomyopathies. N. Engl. J. Med. 364, 1643-1656.
102. Wei, J. Q., Shehadeh, L. A., Mitrani, J. M., Pessanha, M., Slepak, T. I., Webster, K. A. and Bishopric, N. H. (2008). Quantitative control of adaptive cardiac hypertrophy by acetyltransferase p300. Circulation 118, 934-946.
103. Wilusz, J. E., Sunwoo, H. and Spector, D. L. (2009). Long noncoding RNAs: functional surprises from the RNA world. Genes Dev. 23, 1494-1504.
104. Xu, X., Yang, D., Ding, J.-H., Wang, W., Chu, P.-H., Dalton, N. D., Wang, H.-Y., Bermingham, J. R., Jr, Ye, Z., Liu, F. et al. (2005). ASF/SF2-regulated CaMKIIdelta alternative splicing temporally reprograms excitation-contraction coupling in cardiac muscle. Cell 120, 59-72. (Pubitemid 40094603)
105. Yao, T.-P., Oh, S. P., Fuchs, M., Zhou, N.-D., Ch'ng, L.-E., Newsome, D., Bronson, R. T., Li, E., Livingston, D. M. and Eckner, R. (1998). Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300. Cell 93, 361-372. (Pubitemid 28232081)
106. Yazawa, M., Hsueh, B., Jia, X., Pasca, A. M., Bernstein, J. A., Hallmayer, J. and Dolmetsch, R. E. (2011). Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome. Nature 471, 230-234.
107. Zhang, C. L., McKinsey, T. A., Chang, S., Antos, C. L., Hill, J. A. and Olson, E. N. (2002). Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy. Cell 110, 479-488. (Pubitemid 35232291)
108. Zhang, Q.-J., Chen, H.-Z., Wang, L., Liu, D.-P., Hill, J. A. and Liu, Z.-P. (2011). The histone trimethyllysine demethylase JMJD2A promotes cardiac hypertrophy in response to hypertrophic stimuli in mice. J. Clin. Invest. 121, 2447-2456.
109. Zuk, O., Hechter, E., Sunyaev, S. R. and Lander, E. S. (2012). The mystery of missing heritability: genetic interactions create phantom heritability. Proc. Natl. Acad. Sci. USA 109, 1193-1198.